M04AA01 - Allopurinol |
Probably not porphyrinogenic |
PNP |
Mono.Rationale
Pyrimidine derivative. No data pointing to clinically significant CYP-induction. One reference consider it safe and one unsafe.
Mono.ChemicalDescription
Tablets; 100-600 mg/d. Pyrazolopyrimidine. Used in gout where it blocks the enzyme xantine oxidase, thus decreasing plasma levels of uric acid. Rapidly metabolized to oxypyrinol (alloxantine) and other metabolites.
Mono.PersonalCommunication
Andersson C, patient reports: tolerated (n=3).
Mono.IpnetDrugReports
Uneventful use reported in 21 patients with acute porphyria.
Mono.SimilarDrugs
Mono.References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
| 2. | South African List
Porphyria South Africa No longer maintained
|
|
Mono.Tradenames